Skip to main content
. 2019 Jul 11;6(3):74. doi: 10.3390/medicines6030074
Programmed Death Receptor 1 PD-1
Programmed Death-Ligand 1 PD-L1
Cytotoxic T-lymphocyte-associated protein 4 CTLA-4
Checkpoint Inhibition CPI
Tumor Microenvironment TME
Alanine Aminotransferase ALT
Aspartate Aminotransferase AST
Treatment-Related Adverse Events TRAEs
Immune-Related Adverse Events iRAEs
Reactive Oxygen Species ROS
Granulocyte–Macrophage Colony Stimulating Factor GMCSF
Acute Myeloid Leukemia AML
Adeno-Associated Virus AAV
Retroviral Replication Vectors RRV
Hematopoietic Stem Cells HSCs
DNA-encoded Monoclonal Antibodies DMAbs